Back to Search
FRANCESCO CAVALLO, MD
MD
Diagnostic Radiology Physician
NPI: 1992745814IndividualAccepts Medicare
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
J1919(TX)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Class of 1991
Research & Publications (20)
Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma.
PMID 19520760·Clin Chem·2009
8-other
Recent advances in cancer immunotherapy with an emphasis on vaccines.
PMID 19093768·Expert Rev Vaccines·2009
8-other
Socioeconomic effects on meeting physical activity guidelines: comparisons among 32 countries.
PMID 19276860·Med Sci Sports Exerc·2009
4-observational
Subjective health, symptom load and quality of life of children and adolescents in Europe.
PMID 19639258·Int J Public Health·2009
8-other
Murine pneumotropic virus chimeric Her2/neu virus-like particles as prophylactic and therapeutic vaccines against Her2/neu expressing tumors.
PMID 18839427·Int J Cancer·2009
7-preclinical
Defibrotide: a review on clinical use and future development.
PMID 18613771·Expert Opin Biol Ther·2008
6-review
EndoCAS navigator platform: a common platform for computer and robotic assistance in minimally invasive surgery.
PMID 18698670·Int J Med Robot·2008
8-other
ErbB2 transgenic mice: a tool for investigation of the immune prevention and treatment of mammary carcinomas.
PMID 18729063·Curr Protoc Immunol·2008
4-observational
DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma.
PMID 18980988·Clin Cancer Res·2008
7-preclinical
The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians.
PMID 18342307·Eur J Pharmacol·2008
7-preclinical
Systemic targeting of CpG-ODN to the tumor microenvironment with anti-neu-CpG hybrid molecule and T regulatory cell depletion induces memory responses in BALB-neuT tolerant mice.
PMID 18794141·Cancer Res·2008
7-preclinical
Sleep abnormalities in type 2 diabetes may be associated with glycemic control.
PMID 18685806·Acta Diabetol·2008
8-other
Intramammary application of non-methylated-CpG oligodeoxynucleotides (CpG) inhibits both local and systemic mammary carcinogenesis in female BALB/c Her-2/neu transgenic mice.
PMID 18473736·Curr Cancer Drug Targets·2008
7-preclinical
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.
PMID 18505783·Blood·2008
2-rct
Lenalidomide and its role in the management of multiple myeloma.
PMID 18533796·Expert Rev Anticancer Ther·2008
6-review
Hemostatic effects of bortezomib treatment in patients with relapsed or refractory multiple myeloma.
PMID 18515882·Haematologica·2008
3-trial
A randomised controlled clinical trial of nurse-, dietitian- and pedagogist-led Group Care for the management of Type 2 diabetes.
PMID 19169063·J Endocrinol Invest·2008
2-rct
Sca-1 identifies the tumor-initiating cells in mammary tumors of BALB-neuT transgenic mice.
PMID 19048122·Neoplasia·2008
7-preclinical
Integrated audit as a means to implement unit protocols: a randomized and controlled study.
PMID 19018917·J Eval Clin Pract·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12121 RICHMOND AVENUE, SUITE 109
HOUSTON, TX 77082 - Phone
- (281) 455-7618
Quick Facts
- NPI
- 1992745814
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile